myelodysplastic syndromes (MDS) | Clinical Trials Search

Skip to main content

MedPath Trial Home

Organizations News Research

Data Sources:ClinicalTrials.govEU CTRFDAEMANMPATGAHealth CanadaWHO ICTRP

MedPath Trial Home

Search trials. Track pipelines. Understand approvals. With AI-powered intelligence for clinical research.

Product

Clinical Trials
Drug Intelligence
Global Approvals
AI Research
Pricing

Resources

FAQ
Search

Company

News
About
Contact

Legal

Privacy Policy
Terms of Service

Disclaimer: This website provides information retrieval and data analysis services. The content does not constitute medical advice. Eligibility assessments are for reference only and should not replace consultation with qualified healthcare professionals. Data is sourced from public registries and regulatory agencies; MedPath does not guarantee completeness or accuracy. Always verify information with primary sources.

© 2026 MedPath Trial. All rights reserved.

We value your privacy

We use cookies to analyze site traffic and improve your experience. See our Privacy Policy.

27,912 results for “myelodysplastic syndromes (MDS)”

Need more precision?

Filter by phase, recruitment status, country, sponsor, age, and study type.

Refine trial search

LBH589 in Refractory Myelodysplastic Syndromes (MDS)

26 participants · First posted Jan 15, 2008

The National Myelodysplastic Syndromes (MDS) Study

2,115 participants · First posted May 17, 2016

Darbepoetin Alpha in Myelodysplastic Syndromes (MDS)

99 participants · First posted Mar 6, 2007

Azacitidine Plus Deferasirox (ICL670) in Higher Risk Myelodysplastic Syndromes (MDS)

1 participants · First posted Jan 17, 2014

Decitabine and Clofarabine in Higher Risk Myelodysplastic Syndromes (MDS)

42 participants · First posted May 18, 2009

Lirilumab and Nivolumab With 5-Azacitidine in Patients With Myelodysplastic Syndromes (MDS)

10 participants · First posted Nov 6, 2015

Pyrimethamine for Intermediate/High-risk Myelodysplastic Syndromes (MDS)

First posted Feb 20, 2017

Active, not recruiting

A Pilot, Open-Label Study of Luspatercept for Patients With Lower Risk Myelodysplastic Syndromes (MDS)

10 participants · First posted Nov 2, 2023

Azacitidine and Lintuzumab in Treating Patients With Previously Untreated Myelodysplastic Syndromes

7 participants · First posted Oct 19, 2009

Oral Arsenic (ATO) in Low-risk Myelodysplastic Syndromes (MDS)

24 participants · First posted Nov 1, 2024

Page 1 of 2581